Contraceptive Drugs Market Size, Trends and Growth Outlook by Type [Oral Contraceptives (Combined Oral Contraceptive Pills and Progestogen-Only Pills), Topical Contraceptives, Contraceptive Injectables and others], Distribution Channel (Hospital & Clinics, Retail Pharmacy, Online Pharmacy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Contraceptive Drugs Market, by Type

6.1 Overview

6.2 Oral Contraceptives

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1 Combined Oral Contraceptive Pills

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Progestogen-Only Pills

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Topical Contraceptives

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Contraceptive Injectable

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7 Global Contraceptive Drugs Market, by Distribution Channel

7.1 Overview

7.2 Hospital & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Retail Pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Online Pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Contraceptive Drugs Market, by Region

10.1 Overview

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Overview

11.2 Competitive Analysis

Chapter 12. Company Profile

12.1 Bayer AG

12.1.1 Company Overview

12.1.2 Product Type Overview

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Pfizer Inc.

12.2.1 Company Overview

12.2.2 Product Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Teva Pharmaceutical Industries Ltd.

12.3.1 Company Overview

12.3.2 Product Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Merck & Co., Inc.

12.4.1 Company Overview

12.4.2 Product Type Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Mylan N.V.

12.5.1 Company Overview

12.5.2 Product Type Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Allergan Plc

12.6.1 Company Overview

12.6.2 Product Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Agile Therapeutics

12.7.1 Overview

12.7.2 Product Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Piramal Enterprises Ltd.

12.8.1 Overview

12.8.2 Product Type Overview

12.8.3 Financial Overview

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 GlaxoSmithKline PLC

12.9.1 Overview

12.9.2 Product Type Overview

12.9.3 Financial Overview

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Johnson & Johnson

12.10.1 Overview

12.10.2 Product Type Overview

12.10.3 Financial Overview

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Novartis AG

12.11.1 Overview

12.11.2 Product Type Overview

12.11.3 Financial Overview

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Sanofi

12.12.1 Overview

12.12.2 Product Type Overview

12.12.3 Financial Overview

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Others

Chapter 13 Appendix

13.1 References

13.2 Related Reports

LIST OF TABLES

Table 1 Global Contraceptive Drugs Market Synopsis, 2020-2027

Table 2 Global Contraceptive Drugs Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 4 Global Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 5 Global Contraceptive Drugs Market, by Region, 2020-2027 (USD Million)

Table 6 North America: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 7 North America: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 8 US: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 9 US: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 10 Canada: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 11 Canada: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 12 Latin America: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 13 Latin America: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 14 Europe: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 15 Europe: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 16 Western Europe: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 17 Western Europe: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 18 Eastern Europe: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 19 Eastern Europe: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 20 Asia-Pacific: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 21 Asia-Pacific: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Table 22 Middle East & Africa: Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Table 23 Middle East & Africa: Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure of the Global Contraceptive Drugs Market

Figure 3 Market Dynamics of the Global Contraceptive Drugs Market

Figure 4 Global Contraceptive Drugs Market, by Type, 2020-2027 (USD Million)

Figure 5 Global Contraceptive Drugs Market, by Distribution Channel, 2020-2027 (USD Million)

Figure 6 Global Contraceptive Drugs Market, by Region, 2020-2027 (USD Million)

Figure 9 North America: Contraceptive Drugs Market Share, by Country, 2020 (%)

Figure 7 Europe: Contraceptive Drugs Market Share, by Region, 2020 (%)

Figure 8 Western Europe: Contraceptive Drugs Market Share, by Country, 2020 (%)

Figure 9 Asia-Pacific: Contraceptive Drugs Market Share, by Country, 2020 (%)

Figure 10 Middle East & Africa: Contraceptive Drugs Market Share, by Country, 2020 (%)

Figure 11 Global Contraceptive Drugs Market: Company Share Analysis, 2020 (%)

Figure 12 Bayer AG: Key Financials

Figure 13 Bayer AG: Segmental Revenue

Figure 14 Bayer AG: Regional Revenue

Figure 15 Pfizer Inc.: Key Financials

Figure 16 Pfizer Inc.: Segmental Revenue

Figure 17 Pfizer Inc.: Regional Revenue

Figure 18 Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 19 Teva Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 20 Teva Pharmaceutical Industries Ltd.: Regional Revenue

Figure 21 Merck & Co., Inc.: Key Financials

Figure 22 Merck & Co., Inc.: Segmental Revenue

Figure 23 Merck & Co., Inc.: Regional Revenue

Figure 27 Mylan N.V.: Key Financials

Figure 28 Mylan N.V.: Segmental Revenue

Figure 29 Mylan N.V.: Regional Revenue

Figure 30 Allergan Plc: Key Financials

Figure 31 Allergan Plc: Segmental Revenue

Figure 32 Allergan Plc: Regional Revenue

Figure 33 Agile Therapeutics: Key Financials

Figure 34 Agile Therapeutics: Segmental Revenue

Figure 35 Agile Therapeutics: Regional Revenue

Figure 36 Piramal Enterprises Ltd.: Key Financials

Figure 37 Piramal Enterprises Ltd.: Segmental Revenue

Figure 38 Piramal Enterprises Ltd.: Regional Revenue

Figure 39 GlaxoSmithKline PLC: Key Financials

Figure 40 GlaxoSmithKline PLC: Segmental Revenue

Figure 41 GlaxoSmithKline PLC: Regional Revenue

Figure 42 Johnson & Johnson: Key Financials

Figure 43 Johnson & Johnson: Segmental Revenue

Figure 44 Johnson & Johnson: Regional Revenue

Figure 45 Novartis AG: Key Financials

Figure 46 Novartis AG: Segmental Revenue

Figure 47 Novartis AG: Regional Revenue

Figure 48 Sanofi: Key Financials

Figure 49 Sanofi: Segmental Revenue

Figure 50 Sanofi: Regional Revenue